CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients with COVID-19 Infection, Nested in the CORIMUNO-19 Cohort (CORIMUNO19-ECU) - Clinicaltrials.Gov (2020)
. Accessed November 22, 2020 at: